Screeningul aterosclerozei subclinice – ce spun ghidurile?

Slides:



Advertisements
Similar presentations
Coronary Atherosclerosis is a progressive disease ICC Imaging Center Alexandria, Egypt.
Advertisements

Morteza Naghavi, M.D. Society for Heart Attack Prevention and Eradication (SHAPE) Detection and Treatment of Asymptomatic Atherosclerosis for Primary Prevention.
Task Force on Diabetes and CVD (ESC and EASD) European Heart Journal 2007;28:
Ryan Hampton January  Risks and benefits of surgery  Timing of surgery  Type of Surgery  Goal is to uncover undiagnosed problems or treat prior.
New concepts and guidelines in the management of LDL-c and CV Risk: Need for early intervention Prof. Ulf Landmesser University Hospital Zürich Switzerland.
Presenter Disclosure Information Diane Bild, MD, MPH Screening for Subclinical Atherosclerosis as a Strategy for CVD Prevention FINANCIAL DISCLOSURE: None.
Assessment of Target Organ Damage: Established and Novel Methods Christian Delles BHF Glasgow Cardiovascular Research Centre Institute of Cardiovascular.
Canadian Diabetes Association Clinical Practice Guidelines Screening for the Presence of Coronary Artery Disease Chapter 23 Paul Poirier, Robert Dufour,
Coronary Calcium Scoring for Risk Stratification and Guidelines Matthew Budoff, MD, FACC, FAHA Professor of Medicine Director, Cardiac CT Harbor-UCLA Medical.
Surrogate Measures of Atherosclerosis and Implications for Evaluating Cardiovascular Risk Nathan D. Wong, Ph.D., F.A.C.C. Associate Professor and Director.
Only You Can Prevent CVD Matthew Johnson, MD. What can we do to prevent CVD?
Tenth International Symposium HEART FAILURE & Co. CARDIOLOGY SCIENCE UPDATE FEMALE DOCTORS SPEAKING ON FEMALE DISEASES Milano aprile 2010 FEDERICA.
Diagnostic Stress Testing
Exercise Echocardiography Cardiac Issues 2011 Douglass A Morrison, MD, PhD.
20 Cardiovascular Disease and Physical Activity chapter.
Management of Stable Angina SIGN 96
Your role will be – “Yes – we should”
Cardio Investigations. Patients presenting with chest pain may be identified as having definite or possible angina from their history alone. Risk Factor.
Silent Ischemia STABLE CAD
Roles of Nuclear Cardiology, Cardiac Computed Tomography Cardiac Magnetic Resonance: Assessment of Patients with Suspected Coronary Artery Disease INT.
Predictive Value of Coronary Calcium Scoring Matthew Budoff, MD, FACC, FAHA Associate Professor of Medicine UCLA School of Medicine Director, Cardiac CT.
ACC/AHA 2006 guidelines on the management of PAD.
Section III. Assessment of Overall Cardiovascular Risk in Hypertensive Patients 2015 Canadian Hypertension Education Program Recommendations.
Date of download: 5/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: 2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for.
CARDIAC CT IN SCREENING FOR CAD Hossein Nademi MD CARDIOLOGIST JAVADOL-A-EME HEART HOSPITAL OCT
Date of download: 5/31/2016 Copyright © 2016 McGraw-Hill Education. All rights reserved. Evaluation of the patient with known or suspected ischemic heart.
Are We There Yet ? Abdul H. Sankari, MD FACC FCCP.
Date of download: 6/23/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS.
Date of download: 6/25/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010.
Screening for CAD Nuclear Medicine prospective S.R.Zakavi,MD,IBNM Nuclear Medicine Research Center Mashhad University of Medical Sciences.
Indication Contraindication Preparation
Ischaemic heart disease. Coronary artery disease(CAD) is the leading cause of death worldwide. The rates of mortality and disability due to CAD are increasing.
Date of download: 9/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 Appropriate.
A Clinical and Echocardiographic Score for Assigning Risk of Major Events After Dobutamine Echocardiograms JACC Vol. 43, No June 2, 2004:2102–7.
Choosing Wisely: Cardiology Jeffrey Ziffra D.O. Mercy Medical Center – North Iowa 10/14/2016.
Coronary Artery Disease **CAD Risk Stratification**
Women and Cardiovascular Disease
1 Figure 1: Patient Setup and Sample VENDYS DTM Report
Copyright © 2009 American Medical Association. All rights reserved.
Multi Modality Approach to Diagnosis of Ischemia in Post CABG Cases
CT for Evaluation & Treatment of Cardiovascular Disease
Special Hospital for surgical diseases “Filip Vtori”, Skopje
Wm. Guy Weigold, MD, FACC, FSCCT Director of Cardiac CT
PREOPERATIVE EVALUATION in the ELDERLY Module 2 CARDIAC ASSESSMENT
From: Diagnosis of Stable Ischemic Heart Disease: Summary of a Clinical Practice Guideline From the American College of Physicians/American College of.
The European Society of Cardiology Presented by Dr. Bo Lagerqvist
Management strategy for patients with aortic stenosis
The Role of Cardiac CT in Women
Hypertension Hanna K. Al-Makhamreh, MD FACC Interventional Cardiology.
Phenotype vs. Genotype: Defining Severe Familial Hypercholesterolemia
Use of Current CAC Guidelines and CAD Risk Evaluation in Asymptomatic Adult Women Gina Lundberg MD, Quira Woodbury MSc, Stacy Jaskwhich NP, Kevin Viel.
Cholesterol practice questions
The role of treadmill exercise testing in women
Heart Rate, Life Expectancy and the Cardiovascular System: Therapeutic Considerations Cardiology 2015;132: DOI: / Fig. 1. Semilogarithmic.
Post-Surgical Care for the Individual With PAD
Public Health Burden of CAD/PAD
ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012 appropriate use criteria for diagnostic catheterization  Manesh R. Patel, MD, FACC, Steven.
Neil J. Stone et al. JACC 2014;63:
Chapter 1 Benefits and Risks Associated with Physical Activity
Canadian Cardiovascular Society Guidelines for the Diagnosis and Management of Stable Ischemic Heart Disease  G.B. John Mancini, MD, Gilbert Gosselin,
Screening for asymptomatic cardiovascular disease with noninvasive imaging in patients at high-risk and low-risk according to the European Guidelines.
Contemporary Evidence-Based Guidelines
CT coronary angiography and coronary calcium scoring
Correlation between endothelial function and hypertension
Patient Examples of CMR Stress Test in Women Patient #1 is a 70-year-old, post-menopausal woman with typical angina and 3 coronary artery disease (CAD)
HILLSBOROUGH COUNTY SHERIFF’S DEPARTMENT
Cardiovascular Disease in Women Module III: Risk Assessment Tool
Lee A. Fleisher et al. JACC 2014;64:e77-e137
Left Ventricular Mass at MRI and Long-Term Risk of Cardiovascular Events: The Multi-Ethnic Study of Atherosclerosis (MESA) Left ventricular hypertrophy.
Section 6: Update on lipid treatment guidelines
Presentation transcript:

Screeningul aterosclerozei subclinice – ce spun ghidurile? D. Zdrenghea, Cluj-Napoca

TOATA POPULATIA TREBUIE, CEL PUTIN DE LA O ANUMITA VARSTA, INVESTIGATA PENTRU A DEPISTA ATEROSCLEROZA SUBCLINICA?

Uwe Nixdorf et al. The ESC Textbook of Preventive Cardiology, 2015

TOATE METODELE AU ACEEASI VALOARE IN DETECTAREA ATEROSCLEROZEI SUBCLINICE?

Uwe Nixdorf et al. The ESC Textbook of Preventive Cardiology, 2015

CARE METODE SUNT COST- EFICIENTE, SIMPLE SI POT FI LARG UTILIZATE?

2.5. Cardiac and Vascular Tests for Risk Assessment in Asymptomatic Adults 2.5.1. Resting Electrocardiogram 2.5.1.1. Recommendations for Resting Electrocardiogram Class IIa A resting electrocardiogram (ECG) is reasonable for cardiovascular risk assessment in asymptomatic adults with hypertension or diabetes. (Level of Evidence: C) Class IIb A resting ECG may be considered for cardiovascular risk assessment in asymptomatic adults without hypertension or diabetes.202-204 (Level of Evidence: C) Greenland et al. CV Risk Guideline, Circulation 2010

BI, 44 ani, HTA grad II, DZ tip II Clinic: asimptomatic EKG: ritm sinusal, 75/min, BRS major

2.5.2. Resting Echocardiography for Left Ventricular Structure and Function and Left Ventricular Hypertrophy: Transthoracic Echocardiography 2.5.2.1. Recommendations for Transthoracic Echocardiography Class IIb Echocardiography to detect LVH may be considered for cardiovascular risk assessment in asymptomatic adults with hypertension. (Level of Evidence: B) Class III: No Benefit Echocardiography is not recommended for cardiovascular risk assessment of CHD in asymptomatic adults without hypertension. (Level of Evidence: C) Greenland et al. CV Risk Guideline, Circulation 2010

Ecografic: VS hipertrofiat concentric, SIV=14.5mm, PP=14mm

2.5.3. Carotid Intima-Media Thickness on Ultrasound 2.5.3.1. Recommendation for Measurement of Carotid Intima-Media Thickness Class IIa 1. Measurement of carotid artery IMT is reasonable for cardiovascular risk assessment in asymptomatic adults at intermediate risk. Published recommendations on required equipment, technical approach, and operator training and experience for performance of the test must be carefully followed to achieve high-quality results. (Level of Evidence: B) Greenland et al. CV Risk Guideline, Circulation 2010

Ecodoppler carotidian – aspect normal, Grosime intima medie = 0 Ecodoppler carotidian – aspect normal, Grosime intima medie = 0.64, fara placi ATS

PI, barbat, 69 ani, hipertensiv, fumator, dislipidemic, cu 2 AIT in antecedente EcoDoppler: ACC dreapta cu IMT mult crescuta si placi ATS

2.5.4. Brachial/Peripheral Flow-Mediated Dilation 2.5.4.1. Recommendation for Brachial/Peripheral Flow-Mediated Dilation Class III: No Benefit 1. Peripheral arterial flow-mediated dilation (FMD) studies are not recommended for cardiovascular risk assessment in asymptomatic adults. (Level of Evidence: B) Greenland et al. CV Risk Guideline, Circulation 2010

2.5.5. Pulse Wave Velocity and Other Arterial Abnormalities: Measures of Arterial Stiffness 2.5.5.1. Recommendation for Specific Measures of Arterial Stiffness Class III: No Benefit Measures of arterial stiffness outside of research settings are not recommended for cardiovascular risk assessment in asymptomatic adults. (Level of Evidence: C) Greenland et al. CV Risk Guideline, Circulation 2010

EcoDoppler carotidian – fara stenoze carotidiene

2.5.6. Recommendation for Measurement of Ankle-Brachial Index Class IIa 1. Measurement of ABI is reasonable for cardiovascular risk assessment in asymptomatic adults at intermediate risk. (Level of Evidence: B) Greenland et al. CV Risk Guideline, Circulation 2010

AM, barbat, 74 ani, fumator, asimptomatic ABI la consult cardiologic de rutina preoperator pentru hernie inghinala dreapta = 0,6

2.5.7. Recommendation for Exercise Electrocardiography Class IIb 1. An exercise ECG may be considered for cardiovascular risk assessment in intermediate-risk asymptomatic adults (including sedentary adults considering starting a vigorous exercise program), particularly when attention is paid to non-ECG markers such as exercise capacity. (Level of Evidence: B) Greenland et al. CV Risk Guideline, Circulation 2010

Barbat, 49 ani, supraponderal, dislipidemic, cu AHC de infarct miocardic la varsta tanara Test de effort pozitiv pentru ischemie miocardica la 150W Test de effort cardiopulmonar cu capacitate de efort buna (VO2 peak=27ml/min/kg)

Test EKG de effort pozitiv pentru ischemie miocardica

Barbat, 40 ani, supraponderal,LDL 230mg/dl,fumator Test de effort cardiopulmonar cu capacitate de efort buna (VO2 peak=27ml/min/kg)

2.5.8. Recommendation for Stress Echocardiography Class III: No Benefit 1. Stress echocardiography is not indicated for cardiovascular risk assessment in low- or intermediate-risk asymptomatic adults. (Exercise or pharmacologic stress echocardiography is primarily used for its role in advanced cardiac evaluation of symptoms suspected of representing CHD and/or estimation of prognosis in patients with known coronary artery disease or the assessment of patients with known or suspected valvular heart disease.) (Level of Evidence: C) Greenland et al. CV Risk Guideline, Circulation 2010

2.5.9. Myocardial Perfusion Imaging 2.5.9.1. Recommendations for Myocardial Perfusion Imaging Class IIb 1. Stress MPI may be considered for advanced cardiovascular risk assessment in asymptomatic adults with diabetes or asymptomatic adults with a strong family history of CHD or when previous risk assessment testing suggests high risk of CHD, such as a CAC score of 400 or greater. (Level of Evidence: C) Class III: No Benefit 1. Stress MPI is not indicated for cardiovascular risk assessment in low- or intermediate-risk asymptomatic adults. (Exercise or pharmacologic stress MPI is primarily used and studied for its role in advanced cardiac evaluation of symptoms suspected of representing CHD and/or estimation of prognosis in patients with known CAD). (Level of Evidence: C) Greenland et al. CV Risk Guideline, Circulation 2010

NR, barbat, 64 ani, hipertensiv, diabetic in tratament cu insulina de 5 ani Clinic: asimptomatic CT: calcificari coronariene, scor de calciu >400 UA Scintigrafie miocardica de effort: defecte de perfuzie in multiple teritorii vasculare

2.5.10. Computed Tomography for Coronary Calcium 2.5.10.1. Recommendations for Calcium Scoring Methods (see Section 2.6.1) Class IIa 1. Measurement of CAC is reasonable for cardiovascular risk assessment in asymptomatic adults at intermediate risk (10% to 20% 10-year risk). (Level of Evidence: B) Class IIb 1. Measurement of CAC may be reasonable for cardiovascular risk assessment in persons at low to intermediate risk (6% to 10% 10-year risk). (Level of Evidence: B) Class III: No Benefit 1. Persons at low risk (<6% 10-year risk) should not undergo CAC measurement for cardiovascular risk assessment. (Level of Evidence: B) Greenland et al. CV Risk Guideline, Circulation 2010

Uwe Nixdorf et al. The ESC Textbook of Preventive Cardiology, 2015

IR, femeie, 52 ani, hipertensiva Clinic:asimptomatica CT cord:- calcificari la nivelul IVA, scor de calciu = 558 UA -Ct efectuat cu sus[piciunea leziune pulmonara ECG subdenivelare ST semnificativa

CT – calcificari IVA

2.5.11. Coronary Computed Tomography Angiography 2.5.11.1. Recommendation for Coronary Computed Tomography Angiography Class III: No Benefit 1. Coronary computed tomography angiography is not recommended for cardiovascular risk assessment in asymptomatic adults. (Level of Evidence: C) Greenland et al. CV Risk Guideline, Circulation 2010

Uwe Nixdorf et al. The ESC Textbook of Preventive Cardiology, 2015

2.5.12. Magnetic Resonance Imaging of Plaque 2.5.12.1. Recommendation for Magnetic Resonance Imaging of Plaque Class III: No Benefit 1. MRI for detection of vascular plaque is not recommended for cardiovascular risk assessment in asymptomatic adults. (Level of Evidence: C) Greenland et al. CV Risk Guideline, Circulation 2010

2.6. Special Circumstances and Other Considerations 2.6.1. Diabetes Mellitus 2.6.1.1. Recommendations for Patients With Diabetes Class IIa 1. In asymptomatic adults with diabetes, 40 years of age and older, measurement of CAC is reasonable for cardiovascular risk assessment. (Level of Evidence: B) Class IIb 1. Measurement of HbA1C may be considered for cardiovascular risk assessment in asymptomatic adults with diabetes.400 (Level of Evidence: B) 2. Stress MPI may be considered for advanced cardiovascular risk assessment in symptomatic adults with diabetes or when previous risk assessment testing suggests a high risk of CHD, such as a CAC score of 400 or greater. (Level of Evidence: C) Greenland et al. CV Risk Guideline, Circulation 2010

2.6.2.1. Recommendations for Special Considerations in Women Class I A global risk score should be obtained in all asymptomatic women. (Level of Evidence: B) 2. Family history of CVD should be obtained for cardiovascular risk assessment in all asymptomatic women. (Level of Evidence: B) Greenland et al. CV Risk Guideline, Circulation 2010

RECOMANDARILE EUROPENE

European Guidelines on cardiovascular disease prevention in clinical practice. European Heart Journal (2012)

MF Piepoli et al. Joint ESC Guidelines / Atherosclerosis 252 (2016) 207e274

2.4.4. Measurement of preclinical vascular damage MF Piepoli et al. Joint ESC Guidelines / Atherosclerosis 252 (2016) 207e274

2.4.4. Measurement of preclinical vascular damage Key messages Routine screening with imaging modalities to predict future CV events is generally not recommended in clinical practice. Imaging methods may be considered as risk modifiers in CV risk assessment, i.e. in individuals with calculated CV risks based on the major conventional risk factors around the decisional thresholds. Gaps in evidence Currently, most imaging techniques have not been rigorously tested as screening tools in CV risk assessment; more evidence on calibration, reclassification and cost-effectiveness is still needed. The reduction of CVD risk in patients treated with lipid- or BP lowering drugs because of reclassification with, for example, CAC or ABI remains to be demonstrated MF Piepoli et al. Joint ESC Guidelines / Atherosclerosis 252 (2016) 207e274

Fox et al CVD Prevention in Adults With Type 2 Diabetes Mellitus Fox et al CVD Prevention in Adults With Type 2 Diabetes Mellitus. Circulation 2015

Table 8. Screening Tests for Asymptomatic CAD in Patients With Diabetes Mellitus Fox et al CVD Prevention in Adults With Type 2 Diabetes Mellitus. Circulation 2015

Concluzie PANA LA ORA ACTUALA S-AU VALIDAT PENTRU PRACTICA MEDICALA ECG DE REPAUS, IN ANUMITE SITUATII, SI DE EFFORT(TE), ABI, IMT, CT TORACIC CU SCOR DE CALCIU, EVENTUAL IN ANUMITE SITUATII SI IN SPECIAL LA DIABETICI, SCINTIGRAFIA MIOCARDICA DE STRES. RESTUL METODELOR DE DEPISTARE A ATEROSCLEROZEI SUBCLINICE SE VOR UTILIZA DOAR IN SITUATII SPECIALE LA INDICATIA CARDIOLOGULUI.